[go: up one dir, main page]

AU2001258373A1 - Method for identifying helicobacter antigens - Google Patents

Method for identifying helicobacter antigens

Info

Publication number
AU2001258373A1
AU2001258373A1 AU2001258373A AU5837301A AU2001258373A1 AU 2001258373 A1 AU2001258373 A1 AU 2001258373A1 AU 2001258373 A AU2001258373 A AU 2001258373A AU 5837301 A AU5837301 A AU 5837301A AU 2001258373 A1 AU2001258373 A1 AU 2001258373A1
Authority
AU
Australia
Prior art keywords
helicobacter
helicobacter antigens
antigens
identifying helicobacter
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258373A
Inventor
Anton Aebischer
Dirk Bumann
Gaby Haas
Peter Jungblut
Galip Karaali
Stephanie Lamer
Thomas F Meyer
Nicolas Sabarth
Meike Wendland
Ursula Zimny-Arndt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Publication of AU2001258373A1 publication Critical patent/AU2001258373A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for characterizing or identifying proteins which are expressed by cultivated Helicobacter cells and which preferably react with human antisera. Thus, novel Helicobacter antigens are provided which are suitable as targets for the diagnostis, prevention or treatment of Helicobacter infections.
AU2001258373A 2000-04-27 2001-04-26 Method for identifying helicobacter antigens Abandoned AU2001258373A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00108968 2000-04-27
EP00108968 2000-04-27
EP01101439 2001-01-23
EP01101439 2001-01-23
PCT/EP2001/004728 WO2001083531A1 (en) 2000-04-27 2001-04-26 Method for identifying helicobacter antigens

Publications (1)

Publication Number Publication Date
AU2001258373A1 true AU2001258373A1 (en) 2001-11-12

Family

ID=26070866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258373A Abandoned AU2001258373A1 (en) 2000-04-27 2001-04-26 Method for identifying helicobacter antigens

Country Status (6)

Country Link
US (1) US20030180330A1 (en)
EP (1) EP1278768B1 (en)
AT (1) ATE345354T1 (en)
AU (1) AU2001258373A1 (en)
DE (1) DE60124526D1 (en)
WO (1) WO2001083531A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
ATE353337T1 (en) * 1996-06-10 2007-02-15 Thomas Boren ADHESIN FROM HELIOBACTER PYLORI, WHICH BINDS TO BLOOD GROUP ANTIGENS
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
DE60138981D1 (en) * 2000-05-18 2009-07-30 Meridian Bioscience Inc Immunoassay for H. pylori in feces samples using genus-specific antibodies
CA2414846A1 (en) * 2000-07-05 2002-01-24 Merieux Oravax Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
CA2351110A1 (en) * 2000-07-17 2002-01-17 Akzo Nobel N.V. Helicobacter felis vaccine
JP2005502030A (en) * 2001-05-29 2005-01-20 リージェンツ オブ ザ ユニバーシティ オブ ミシガン Protein analysis system and method
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
EP1837345A1 (en) * 2006-03-23 2007-09-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pharmaceutical compositions comprising cholesteryl-alpha-glucosyltransferase for the treatment of Helicobacteri pylori infections
WO2016000022A1 (en) 2014-06-30 2016-01-07 Murdoch Childrens Research Institute Helicobacter therapeutic
BR112018012033A2 (en) 2015-12-14 2018-12-04 Max Planck Gesellschaft immunogenic composition and method for detecting h infection. pylori in a subject
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111793137A (en) * 2019-12-12 2020-10-20 南京蛋球球生物医学技术合伙企业(有限合伙) Hp tetravalent antigen and preparation method and application thereof
JP6867529B1 (en) * 2020-03-16 2021-04-28 栄研化学株式会社 Helicobacter pylori detection antibody
CN114907491B (en) * 2022-06-21 2023-06-16 中国科学院西北生态环境资源研究院 Multi-epitope peptide, helicobacter pylori octavalent multi-epitope vaccine and preparation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US52799A (en) * 1866-02-20 Improved apparatus for driving metal or wood into the ground
US115078A (en) * 1871-05-23 Improvement in whiffletrees
US158396A (en) * 1875-01-05 Improvement in street-lamps
US160456A (en) * 1875-03-02 Improvement in locomotive spark-arresters
DE69529219T2 (en) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville HELICOBACTER PROTEINS AND VACCINES
KR19990007828A (en) * 1995-04-21 1999-01-25 피터 터비 Helicobacter Infection Defense Antigen
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE
EP0835928A1 (en) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter pylori live vaccine
US20040052799A1 (en) * 1996-11-15 2004-03-18 Astra Aktiebolag Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
WO1998043478A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
WO1998049314A2 (en) * 1997-04-25 1998-11-05 Genelabs Technologies, Inc. ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism

Also Published As

Publication number Publication date
WO2001083531A1 (en) 2001-11-08
EP1278768B1 (en) 2006-11-15
ATE345354T1 (en) 2006-12-15
DE60124526D1 (en) 2006-12-28
EP1278768A1 (en) 2003-01-29
US20030180330A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2001258373A1 (en) Method for identifying helicobacter antigens
EP1553975B8 (en) Optimized fc variants and methods for their generation
WO2001014424A3 (en) Human ctla-4 antibodies and their uses
AU2001269742A1 (en) Method of treating gastrointestinal diseases associated with species of genus clostridium
WO2000043781A3 (en) Growth differentiation factor inhibitors and uses therefor
WO2005074607A3 (en) Method of treating hemolytic disease
WO2001034801A3 (en) Recombinant gelatin in vaccines
ATE551352T1 (en) PEPTIDE ACCEPTOR BINDING METHOD
AU5630999A (en) Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
WO2004009774A3 (en) Protein conjugates with a water-soluble biocompatible, biogradable polymer
IL166021A0 (en) Trabsolant acceptance inducing cells of monocytic origin and their preparation and use
AU2003275612A1 (en) Defructosylation method
GB0114853D0 (en) Happier Mapping
AU2001293202A1 (en) Process for extracting compounds from plants
WO2003075953A3 (en) Immunomodulatory polymeric antigens for treating inflammatory pathogies
AR030735A1 (en) A PROCEDURE FOR THE PRODUCTION OF A NATURAL CHAMPINON EXTRACT
AU2003236817A1 (en) Plant extracts
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
WO2001054707A3 (en) Modification of surface proteins by aminopeptidase inhibitors
AU2003205751A1 (en) Plant growth modulation by drl1 and other proteins of the elongator complex
ID27733A (en) METHODIMINOFENILASETAMIDA
WO2005046581A3 (en) P18 in stem cell manipulations
DE69838615D1 (en) ppGpp-Synthetase and expression systems for the improved production of proteins
AU2002249173A1 (en) Phosphorylated glyoxalase i and its use